Lexaria Bioscience

Youtube Subscribe

Open: 1.32 Close: 1.29 Change: -0.03

Stop waiting time to find out about Lexaria Bioscience: Our AI summarizes all info about it.

How much time have you spent trying to decide whether investing in Lexaria Bioscience? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Lexaria Bioscience are: …

Concept Map

Semantic Network

Stock Summary

Lexaria Bioscience Corp. develops and out-licenses its DehydraTECH technology. Company's DehydaTECH combines lipophilic molecules with specific long-chain fatty acids. Technology evaluates for a variety of.

Today's Summary

Lexaria Bioscience Corp (LEXX) stock is trading at $1.31 as of 10:02 AM on Monday, Dec 18, a gain of $0.04, or 3.14% from the previous closing price of $1.27. Lexaria bioscience (nasdaq: lexx) targeting new and more lucrative global markets. Lexarias patented DehydraTECH(TM), “drug delivery platform tech KamBloomorceBron@ Lexaria Bioscience Corp. (LEXX) vs. edesa biotech (nasdaq:edsa) financial comparison - defense world.com. Lexaria has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500. Edesa Biotech is currently the more affordable of the two stocks.

Today's News

Lexaria Bioscience Corp (LEXX) stock is trading at $1.31 as of 10:02 AM on Monday, Dec 18, a gain of $0.04, or 3.14% from the previous closing price of $1.27. Lexaria bioscience (nasdaq: lexx) targeting new and more lucrative global markets. Lexarias patented DehydraTECH(TM), “drug delivery platform tech KamBloomorceBron@ Lexaria Bioscience Corp. (LEXX) vs. edesa biotech (nasdaq:edsa) financial comparison - defense world.com. Lexaria has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500. Edesa Biotech is currently the more affordable of the two stocks.

Stock Profile

"Lexaria Bioscience Corp. operates as a biotechnology company. The company develops and out-licenses its DehydraTECH combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and various cannabinoids. The company's DehydraTECH technology evaluates for a variety of therapeutic indications, including hypertension, heart disease, dementia, and diabetes. It is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is based in Kelowna, Canada."

Keywords

Are looking for the most relevant information about Lexaria Bioscience? Investor spend a lot of time searching for information to make investment decisions in Lexaria Bioscience. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Lexaria Bioscience are: Lexaria, Bioscience, Corp, LEXX, stock, price, trading, and the most common words in the summary are: inc, follow, nasdaq, bioscience, stock, lexaria, corp, . One of the sentences in the summary was: Edesa Biotech is currently the more affordable of the two stocks.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #inc #follow #nasdaq #bioscience #stock #lexaria #corp.

Read more →

Youtube Subscribe

---